The European Medicines Agency says it will convene a meeting on Dec. 29 to decide if there is enough data about the safety and efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech for it to be approved
Related posts
-
Transit’s fiscal cliff gets steeper as leaders warn of ‘death spiral’
Metra, Pace and the CTA delivered their 2025 budgets to the RTA Friday but the big... -
Student-designed nutcrackers on display this weekend in Rosemont
More than two dozen human-sized nutcrackers sculptures custom painted by high school students went on display... -
All on board: Bensenville rallies behind food pantry after holiday train schedule change
Bensenville rallied to collect money and items for a community food pantry after learning a holiday...